HSD17B13 and fatty liver disease: Fenretinide treatment also repressed Hsd17b13 expression in parallel with the prevention of liver steatosis in the LDLR−/− mice fed‐HFD plus high cholesterol diet model of dyslipidaemia (Figure 2d) (Thompson et al., 2023).